With the products not bundled the oxymorphone patch is worth no more than the BEMA. buprenorphine as a % of peak sales.
That does surprise me.
Again this is the independant valuation of the now disappeared oxycodone systemic patch"* Oxy C independent external valuation $500m post Phase II ** $900m post Phase III" from the 2013 agm slide.
Ultimately, even if POH get a $50mill up front it will keep the wheels turning.(is this the bargain basement deal you want Playez?) But where does. POH get the pay day? Is it a very hefty back end royalty attached to sales? With current specualtion I dont see how POH cashes in on having a mega blockbuster.
Is no one else willing to have a crack other than Jev and HT?
Compare a deal - Endo - cheeky, page-22
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 40522233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 40065430 | 31 |
View Market Depth
| Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |